This integrated guidance on health clearance and the management of healthcare workers living with bloodborne viruses brings together the current guidance on the management of bloodborne viruses in healthcare workers; it includes guidance on clearance and monitoring of healthcare workers who undertake exposure-prone procedures and advice on the investigation and management of any healthcare workers found to have a bloodborne virus.
This guidance provides information on:
- health clearance for hepatitis B, hepatitis C and HIV for new healthcare workers
- management of healthcare workers infected with hepatitis B, hepatitis C or HIV, including monitoring arrangements for those performing exposure prone procedures
- guidance and arrangements for undertaking patient notification exercises following the diagnosis of healthcare workers with hepatitis B, hepatitis C or HIV
- roles and responsibilities of the
UK Advisory Panel on healthcare workers with blood borne viruses (UKAP) and other parties involved in the management of healthcare workers infected with hepatitis B, hepatitis C or HIV
The diagnosis and treatment of blood-borne viruses is a rapidly evolving field, with new highly effective treatments being used which change the impact of bloodborne virus infection on a healthcare worker’s ability to practice. As new developments come into use, the UK Advisory Panel will review their impact on existing recommendations and guidance will be updated accordingly.